Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novagold Resources Inc. (NG) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Novagold Resources Inc.Trade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Novagold Resources Inc. vs Vir Biotechnology Inc. Common Stock — how do they compare? Novagold Resources Inc. trades at $6.37 (market cap $2.90B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Novagold Resources Inc. is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Novagold Resources Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Novagold Resources Inc. for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

NGVIR
Market Cap
$2.90B$1.80B
Volume
3,973,4641,782,836
Sector
Basic MaterialsHealth
52-Week High
$14.20$11.78
52-Week Low
$5.18$5.12
Typical Hold Time
0 Days0 Days
Enterprise Value
$2.74B$1.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Novagold Resources Inc.

NovaGold Resources (NG) trades at $6.63, down 1.49% today, as the company navigates its development phase for the Donlin Gold project. The stock shows mixed earnings performance with recent quarterly losses but beats expectations in two of the last four quarters. Financials reveal negative profitability metrics with ROE at -32.81% and net income of -$94.66M for 2025, though cash flow remains positive due to financing activities. Recent news highlights the company's move to acquire full ownership of Donlin Gold, a major Alaska gold project.

The outlook for NG hinges on successful development of Donlin Gold, with 100% analyst buy ratings signaling strong Wall Street confidence. However, significant execution risks exist given negative earnings and substantial capital requirements. Investors face volatility from gold price fluctuations and project development timelines, making this suitable for those with high risk tolerance seeking exposure to a major gold development story.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

NG
100% Buy0% Sell
Avg holding period · 0 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About Novagold Resources Inc.

NovaGold Resources Inc. is a mineral exploration and development company that holds a majority interest in the Donlin Gold project, an undeveloped gold deposit in Alaska.

Read more on NG →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →